A B cell–driven EAE mouse model reveals the impact of B cell–derived cytokines on CNS autoimmunity
Proceedings of the National Academy of Sciences · 2023
DOI: 10.1073/pnas.2300733120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023. Verfasst von Anna S Thomann und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Neuroimmunology, University Hospital Ludwig-Maximilians-Universität München, Planegg-Martinsried 82152, Germany. Hauptthemen laut MEDLINE: Encephalomyelitis, Autoimmune, Experimental, Multiple Sclerosis. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Forschungsgemeinschaft (DFG).
Abstract (Originalsprache)
In multiple sclerosis (MS), pathogenic T cell responses are known to be important drivers of autoimmune inflammation. However, increasing evidence suggests an additional role for B cells, which may contribute to pathogenesis via antigen presentation and production of proinflammatory cytokines. However, these B cell effector functions are not featured well in classical experimental autoimmune encephalomyelitis (EAE) mouse models. Here, we compared properties of myelin oligodendrocyte glycoprotein (MOG)-specific and polyclonal B cells and developed an adjuvant-free cotransfer EAE mouse model, where highly activated, MOG-specific induced germinal center B cells provide the critical stimulus for disease development. We could show that high levels of MOG-specific immunoglobulin G (IgGs) are not required for EAE development, suggesting that antigen presentation and activation of cognate T cells by B cells may be important for pathogenesis. As our model allows for B cell manipulation prior to transfer, we found that overexpression of the proinflammatory cytokine interleukin (IL)-6 by MOG-specific B cells leads to an accelerated EAE onset accompanied by activation/expansion of the myeloid compartment rather than a changed T cell response. Accordingly, knocking out IL-6 or tumor necrosis factor α in MOG-specific B cells via CRISPR-Cas9 did not affect activation of pathogenic T cells. In summary, we generated a tool to dissect pathogenic B cell effector function in EAE development, which should improve our understanding of pathogenic processes in MS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Clinical Neuroimmunology, University Hospital Ludwig-Maximilians-Universität München, Planegg-Martinsried 82152, Germany.
- Biomedical Center, Faculty of Medicine, Ludwig-Maximilians-Universität München, Planegg-Martinsried 82152, Germany.
- Max Planck Institute for Biological Intelligence, Planegg-Martinsried 82152, Germany.
- Research Institute for Biomedical Sciences, Tokyo University of Science, Noda, Chiba 278-0022, Japan.
ORCID-Profile: Anna S Thomann, Courtney A McQuade, Anna Kolz, Rosa Schmitz, Daisuke Kitamura
Förderung
- Deutsche Forschungsgemeinschaft (DFG)
Zitieren
APA
Thomann, A. S., McQuade, C. A., Pinjušić, K., Kolz, A., Schmitz, R., Kitamura, D., Wekerle, H., & Peters, A. (2023). A B cell–driven EAE mouse model reveals the impact of B cell–derived cytokines on CNS autoimmunity. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2300733120
Vancouver
Thomann AS, McQuade CA, Pinjušić K, Kolz A, Schmitz R, Kitamura D, et al. A B cell–driven EAE mouse model reveals the impact of B cell–derived cytokines on CNS autoimmunity. Proceedings of the National Academy of Sciences. 2023. doi:10.1073/pnas.2300733120
BibTeX
@article{Thomann2023,
author = {Thomann, Anna S and McQuade, Courtney A and Pinjušić, Katarina and Kolz, Anna and Schmitz, Rosa and Kitamura, Daisuke and Wekerle, Hartmut and Peters, Anneli},
title = {A B cell–driven EAE mouse model reveals the impact of B cell–derived cytokines on CNS autoimmunity},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
doi = {10.1073/pnas.2300733120}
}
EUVIMED